Related Experiment Video
Updated: Aug 27, 2025
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
May the robotic approach expand the indications for redo surgery in recurrent pNETs in Multiple Neuroendocrine
Carolina Baz1, Nicolas H Dreifuss1, Antonio Cubisino1
1Division of General, Minimally Invasive and Robotic Surgery, Department of Surgery, University of Illinois at Chicago, Chicago, IL, USA.
Abstract:
Pancreatic neuroendocrine tumors (pNETs) represent the leading cause of disease-specific mortality in patients with Multiple Neuroendocrine Neoplasia type 1 (MEN1). Although surgery is the recommended treatment for non-functional pNETs >2 cm, the management of recurrent lesions between 1 and 2 cm is controversial. Robotic surgery was used on a 29-year-old female with MEN1 and previous distal splenopancreatectomy that presented with a 1 cm recurrent pNET. The advantages offered by this approach facilitating a precise resection of the tumor and minimizing the postoperative morbidity may favor the decision towards redo surgery for local recurrences <2 cm, expanding current indications.
Insights
Robotic surgery offers a precise option for recurrent pancreatic neuroendocrine tumors (pNETs) in Multiple Endocrine Neoplasia type 1 (MEN1) patients. This approach may expand surgical indications for smaller, recurrent pNETs, improving outcomes.
Area of Science:
- Endocrinology
- Surgical Oncology
- Genetics
Background:
- Pancreatic neuroendocrine tumors (pNETs) are a primary cause of mortality in Multiple Endocrine Neoplasia type 1 (MEN1).
- Surgical resection is standard for non-functional pNETs >2 cm, but management of recurrent lesions <2 cm remains debated.
